drugset

drugset / Trial / NCT00319514

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

NCT00319514 ↗

Phase 2 Completed 78 enrolled Gachon University Gil Medical Center

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the toxicity and efficacy of docetaxel and cisplatin combination on two schedules in patients with previously untreated, advanced NSCLC.

Timeline

Start: 2004-04
Primary completion: —
Completion: 2006-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Docetaxel	Small molecule	75 mg/m2	—

Indications